Tumefactive demyelination in a patient with human immunodeficiency virus

Isaac H. Solomon; Richard J. Perrin; David B. Clifford; Beau M. Ances

doi:10.1007/s13365-013-0165-y

Tumefactive demyelination in a patient with human immunodeficiency virus

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	265-269
Number of pages	5
Journal	Journal of NeuroVirology
Volume	19
Issue number	3
DOIs	https://doi.org/10.1007/s13365-013-0165-y
State	Published - Jun 2013

Access to Document

10.1007/s13365-013-0165-y

Cite this

@article{69174fa9100444098f1130ed045c0257,

title = "Tumefactive demyelination in a patient with human immunodeficiency virus",

author = "Solomon, \{Isaac H.\} and Perrin, \{Richard J.\} and Clifford, \{David B.\} and Ances, \{Beau M.\}",

note = "Funding Information: Funding sources include National Institute of Allergy and Infectious Diseases (NIAID) (UM1AI069495) (DBC), National Institute of Mental Health (NIMH) (K23MH081786) (BMA), National Institute of Neurological Disorders and Stroke (NINDS) (U10NS077384) (DBC) and (F30NS063547) (IHS), National Institute of Nursing Research (NINR) (R01NR012907 and R01NR012657) (BMA), NM22005 (DBC), and Alzheimer{\textquoteright}s Association (with partial support from Lilly and Roche) (BMA and DBC). DBC has consulted for Pfizer, Genzyme, Millennium, Brinker, Biddle, Reath, Amgen, Quintiles, Biogen Idec, Arnold Todara and Welch.",

year = "2013",

month = jun,

doi = "10.1007/s13365-013-0165-y",

language = "English",

volume = "19",

pages = "265--269",

journal = "Journal of NeuroVirology",

issn = "1355-0284",

number = "3",

}

TY - JOUR

T1 - Tumefactive demyelination in a patient with human immunodeficiency virus

AU - Solomon, Isaac H.

AU - Perrin, Richard J.

AU - Clifford, David B.

AU - Ances, Beau M.

N1 - Funding Information: Funding sources include National Institute of Allergy and Infectious Diseases (NIAID) (UM1AI069495) (DBC), National Institute of Mental Health (NIMH) (K23MH081786) (BMA), National Institute of Neurological Disorders and Stroke (NINDS) (U10NS077384) (DBC) and (F30NS063547) (IHS), National Institute of Nursing Research (NINR) (R01NR012907 and R01NR012657) (BMA), NM22005 (DBC), and Alzheimer’s Association (with partial support from Lilly and Roche) (BMA and DBC). DBC has consulted for Pfizer, Genzyme, Millennium, Brinker, Biddle, Reath, Amgen, Quintiles, Biogen Idec, Arnold Todara and Welch.

PY - 2013/6

Y1 - 2013/6

UR - https://www.scopus.com/pages/publications/84879832153

U2 - 10.1007/s13365-013-0165-y

DO - 10.1007/s13365-013-0165-y

M3 - Article

C2 - 23645348

AN - SCOPUS:84879832153

SN - 1355-0284

VL - 19

SP - 265

EP - 269

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

IS - 3

ER -

Tumefactive demyelination in a patient with human immunodeficiency virus

Access to Document

Other files and links

Cite this